(1 - 23 from 29
)
Pfizer's Paxlovid antiviral drug lowered risk of long Boston Heraldwww.bostonherald.com › › pfizers-paxlovid-antiviral-drug-lo...
www.bostonherald.com
4 days ago · ... are more prone to bias than a randomized trial, said Bob Wachter, chair of medicine at the University of California, San Francisco.
Pfizer's Paxlovid antiviral drug lowered risk of long Star Tribunewww.startribune.com › pfizer-s-paxlovid-antiviral-drug-lowered-risk-of-lo...
www.startribune.com
4 days ago · ... are more prone to bias than a randomized trial, said Bob Wachter, chair of medicine at the University of California, San Francisco.
Pfizer's Paxlovid anti-viral seen to lower long-COVID risk in studywww.japantimes.co.jp › news › › world › science-health-world
www.japantimes.co.jp
4 days ago · ... are more prone to bias than a randomized trial, said Bob Wachter, chair of medicine at the University of California, San Francisco.
Coronavirus Data in California: Dr. Bob Wachter of U.C.S.F. on Testingwww.nytimes.com › › coronavirus-california-new-york-testing
www.nytimes.com
Apr 1, · Dr. Bob Wachter, a professor and chair of the University of California, San Francisco's department of medicine, has been posting updates on ...
sorted by relevance / date